MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Correlation Between Daily Vitamin Intake and Clinical Severity of Parkinson’s in Northeastern Mexico: An Exploratory Study

    R. Trejo-Ayala, P. Ancer-Rodríguez, M. Herrera-López, K. Chapa-Ancer, J. Bermudes-Mendoza, A. Trejo-Ayala, R. Enriquez-Menchaca, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

    Objective: To correlate daily vitamin intake, assessed via a 24-hour dietary recall, with clinical severity measured by the Movement Disorders Society Unified Parkinson's Disease Rating…
  • 2026 International Congress

    Nine-Year Outcome of MRI Guided Focused Ultrasound Thalamotomy in Essential Tremor Patients

    I. Schlesinger, M. Nassar, A. Sinai, I. Senderova, M. Katson, M. Constantinescu, M. Zaaroor, L. Lev Tov (Haifa, Israel)

    Objective: To assess the 9-year outcome of unilateral MRI guided focused ultrasound (MRgFUS) ventral intermediate nucleus thalamotomy in Essential Tremor (ET) patients, with medication resistant…
  • 2026 International Congress

    Non-Motor Phenotypes and Intestinal Microbiome Alterations in GBA1-Associated Parkinson’s Disease: Evidence for a Body-First Subtype

    I. Miliukhina, E. Kryukova, S. Pchelina (Saint-Petersburg, Russian Federation)

    Objective: To characterize the clinical and microbial features of sporadic PD (sPD) and GBA1-associated PD (GBA1-PD), with a particular focus on Escherichia coli abundance, stratified…
  • 2026 International Congress

    Phase 1 Study of BT-267, a potent, selective, brain-penetrant, and oral small molecule inhibitor of LRRK2

    T. Dam, D. Hilt, E. Remeeva, A. Mathias, M. Mcgill, K. Dokukina, A. Pushechnikov, R. Karapetyan, V. Kazey, I. Dukes, N. Savchuk (Dover, USA)

    Objective: The aim of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BT-267 in healthy adults. Background: Leucine rich repeat kinase…
  • 2026 International Congress

    Personalized Factors Influencing Technological Solutions for Mobility – Insights from A Wearable Device in Parkinsons Disease

    A. Desai, R. Rajput (Mumbai, India)

    Objective: To evaluate factors influencing responsiveness to a wearable vibration-based neuromodulation device (WALK) for Freezing of Gait in individuals with Parkinson's disease. Background: Freezing of…
  • 2026 International Congress

    Monitoring Levodopa Responsiveness in Parkinson’s disease using wearable sensors: the digital levodopa challenge

    A. Rizzardi, A. Bonito, C. Zatti, N. Agostini, A. Magliozzi, G. Foresti, K. Eshja, C. Hansen, R. Romijnders, W. Maetzler, A. Pilotto, A. Padovani (Brescia, Italy)

    Objective: To investigate acute and short-term motor responses to Levodopa in drug-naive PD patients using combined clinical assessment and wearable sensor-based gait analysis. Background: Levodopa…
  • 2026 International Congress

    Handwriting Based Screening of Parkinson’s Disease Using Image Analysis of Drawing Tasks

    A. Shih, L. Cruz-Mondragon, V. Santini, S. Panchawagh (Winston-Salem, USA)

    Objective: To evaluate whether image-based analysis of handwriting drawing tasks can distinguish Parkinson's disease from healthy controls. Background: Fine motor impairment is a core feature…
  • 2026 International Congress

    The Correlation Between Serum Uric Acid Levels And The Severity Of Parkinson’s Disease

    D. Prihananti, E. Pasmanasari (Semarang, Indonesia)

    Objective: This study aims to analyze the correlation between serum uric acid levels and the severity of Parkinson's disease. Background: Uric acid has been implicated…
  • 2026 International Congress

    An artificial intelligence-based model to predict Parkinson’s disease risk: the AI-PRA study protocol.

    SV. Virameteekul, S. Hadjidimitriou, I. Gerasimou, C. Sotirakis, L. Hadjileontiadis, M. Almarcha-Menargues, B. Falkenburger, O. Sánchez-Soliño, K. Michailidou, M. Zanti, P. Chairta, K. Christodoulou, M. Kurtis, M. Fabbri, N. Del Campo, A. Noyce, E. de Pablo-Fernández (London, United Kingdom)

    Objective: To present the protocol of the Artificial Intelligence-based Parkinson’s Risk Assessment (AI-PRA) study which aims to validate a novel personalised PD risk prediction model…
  • 2026 International Congress

    The Impact of Delaying Subcutaneous Device-Aided Therapy for Patients with Advanced Parkinson’s Disease

    R. Wiggins, J. Lee, T. Boodhna, O. Yip, J. Homola, L. Pronk, R. van Den Puttelaar, J. Aldred (Charlotte, USA)

    Objective: This study aims to evaluate the clinical, humanistic, and societal impact of delayed SC therapy in patients with PD. Background: As Parkinson’s disease (PD)…
  • « Previous Page
  • 1
  • …
  • 101
  • 102
  • 103
  • 104
  • 105
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley